Lymphocyte Activation in the Pathogenesis of Psoriasis
- 1 July 1997
- journal article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 109 (1) , 1-4
- https://doi.org/10.1111/1523-1747.ep12276285
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Staphylococcal Toxins and Protein A Differentially Induce Cytotoxicity and Release of Tumor Necrosis Factor–α From Human KeratinocytesJournal of Investigative Dermatology, 1996
- Pulling the trigger on psoriasisNature, 1996
- Response of psoriasis to a lymphocyte-selective toxin (DAB389IL-2) suggests a primary immune, but not keratinocyte, pathogenic basisNature Medicine, 1995
- T-Cell-Receptor Repertoire in Chronic Plaque-Stage Psoriasis Is Restricted and Lacks Enrichment of Superantigen-Associated Vβ RegionsJournal of Investigative Dermatology, 1995
- CD8+ T cells in psoriatic lesions preferentially use T-cell receptor V beta 3 and/or V beta 13.1 genes.Proceedings of the National Academy of Sciences, 1994
- Overexpression of vascular permeability factor/vascular endothelial growth factor and its receptors in psoriasis.The Journal of Experimental Medicine, 1994
- Group A streptococcal antigen-specific T lymphocytes in guttate psoriatic lesionsBritish Journal of Dermatology, 1993
- Detection of interferon-gamma mRNA in psoriatic epidermis by polymerase chain reactionJournal of Dermatological Science, 1991
- Oral Cyclosporine in the Treatment of Inflammatory and Noninflammatory DermatosesArchives of Dermatology, 1990
- Epidermal T lymphocytes and HLA-DR expression in psoriasisBritish Journal of Dermatology, 1984